Andrew Ahmann is an Endocrinology/Metabolic physician affiliated with Oregon Health & Science University. OpenAlex indexes 157 publications with 12,207 citations (h-index 44); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-5732Registry record last updated 8 Jul 2007.
Clinical trials
- The Effect of Betahistine on Body Weight in Obese Subjects
Sponsor: OBEcure Ltd.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20252 payments
- Medtronic, Inc.Program year202410 payments
- Novo Nordisk IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1998–2001 per NIH RePORTER. The latest:
- HIGH MONO FAT DIET VERSUS LOW FAT DIET FOR DIABETIC PATIENTS
Oregon Health and Science University
FY2001$172,411M01RR000334 - HIGH MONO FAT DIET VERSUS LOW FAT DIET FOR DIABETIC PATIENTS
Oregon Health and Science University
FY2001M01RR000334 - HIGH MONO FAT DIET VERSUS LOW FAT DIET FOR DIABETIC PATIENTS
Oregon Health and Science University
FY2000M01RR000334
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
New England Journal of Medicine
2025 - Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
JAMA Internal Medicine
2023 - Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Diabetes Technology & Therapeutics
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”